JONATHAN STILL: Open Payments
NPI 1467507178 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 18 payments from 7 companies in 2025. Trend: 2023 $138 · 2024 $418 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $193 |
| Janssen Pharmaceuticals, Inc | 3 | $78 |
| ABBVIE INC. | 2 | $57 |
| Alkermes, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Lundbeck LLC | 1 | $23 |
| Almatica Pharma LLC | 1 | $20 |
Products named: REXULTI, VRAYLAR, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ARISTADA, CAPLYTA, SPRAVATO, LOREEV XR.
Industry payments across NV — which companies pay providers there.
